FDA Approves Global Blood Therapeutics Sickle Cell Disease Drug
(Reuters) – The U.S. Food and Drug Administration said on Monday it approved a drug from Global Blood Therapeutics Inc to... Continue Reading
CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data
Nov 19, 2019 CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data From First Two Patients Treated With Investigational CRISPR/Cas9... Continue Reading
US approves new drug to manage sickle cell disease
By LINDA A. JOHNSON | November 15, 2019 | APNews.com U.S. regulators on Friday approved a new medicine that can help... Continue Reading
Novartis Adakveo approved by FDA for Sickle Cell Disease
New Novartis medicine Adakveo® (crizanlizumab-tmca) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease Sickle... Continue Reading